Kassi Jackson, Editor

A look back on what's happened in optometry during the week of Jan. 21-Jan. 26.

In this first episode of a practice management series with Maria Sampalis, OD, learn about the importance of a brand for your optometric practice.

Essence Johnson, OD, FAAO, Dipl ABO, has been appointed as the first Black EyeCare Perspective executive director.

A look back on what's happened in optometry during the week of Jan. 14-Jan. 19.

IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying emergency department patients with sepsis and contribute to rapid life-saving decisions.

Company magnifies impact of sustainability program as it celebrates milestone: 100 million plastic bottles prevented from reaching Earth’s oceans

A look back on what's happened in optometry during the week of Jan. 7-Jan. 12, 2023.

A look back on what's happened in optometry during the week of Jan. 1-Jan. 5, 2023.

The 'Screen, Protect, Cure' campaign aims to education individuals who may be at risk for glaucoma, while raising funding for glaucoma research during Glaucoma Awareness Month.

Leo Semes, OD, FAAO, shares key highlights from his EyeCon 2022 presentation, "Advances in therapies for retinal disease."

As 2022 comes to a close, check out some of the hottest and most-liked stories from the year!

Marc R. Bloomenstein, OD, FAAO, gives an overview of the SAHARA study.

Selina McGee, OD, FAAO, founder and owner of BeSpoke Vision in Edmond, Oklahoma, shares key takeaways from her discussion, "Pro- and Anti-Inflammatory Cytokine Levels in Tears of Dry Eye Subjects,“ which she presented during the 2022 American Academy of Optometry meeting in San Diego.

Jacqueline Theis, OD, FAAO, gives key takeaways from her AAOpt 2022 meeting presentation, "Ocular and visual complications of Parkinson's disease."

Roland Mattern, director of marketing for eSight, illustrates the use of the company's eSight 4 device to assist patients with central vision loss.

Bindu Manne, lead of Market Development for Ocuphire, shares a company update.

John Buch, OD, MS, with JJV, shares an update on the company's HEV filter contact lens.

Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.

Denise A. Valenti, OD, FAAO, gives key takeaways from her AAOpt 2022 discussion on the impact of marijuana use and driving.

Pinakin Davey, PhD, OD, FAAO, gives key highlights from his AAOpt 2022 presentation, "Management of digital eye strain: comprehensive strategy and nutritional approach."

Jim Sluck, VP of Marketing for Sight Sciences' TearCare, shares the impetus behind the company's fair access campaign.

Nidhi Rana, OD, discusses key highlights from her AAOpt 2022 presentation on pediatric red eye.

Derek Cunningham, OD, FAAO, gives key takeaways from his AAOpt 2022 discussion, "Back to the basics: The importance of treating inflammation AND obstruction for dry eye."

Jeff Nau, PhD, president and CEO of Oyster Point Pharma shares an update on the company's Tyrvaya product.

Optometry Times' EyeCon co-chairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, MA, OD, FAAO, reflect on the 2023 EyeConversations keynote address, which covered new technology, artificial intelligence, and an update in pharmacology.

Graham Erickson, OD, gives key takeaways from his discussion titled, "Optimizing visual performance for sports,"

The positive 3-month efficacy and safety results from Azura Ophthalmic's Phase 2b study of AZR-MD-001 0.5% in Meibomian Gland Dysfunction (MGD) met its co-primary endpoints.

Sherrol Reynolds, OD, gives key takeaways from her co-presentation on the most common autoimmune diseases and their latest updates, which she discussed at AAOpt 2022.

Stephanie Woo, OD, FAAO, FSLS, and S. Barry Eiden, OD, FAAO, discuss the Keratoconus Essentials Program, a joint effort between Woo University and the International Keratoconus Academy.

This acquisition for Alcon means a growing ophthalmic portfolio of commercial products and development pipeline.